These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 7696179

  • 41. Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells.
    Winzen R, Wallach D, Engelmann H, Nophar Y, Brakebusch C, Kemper O, Resch K, Holtmann H.
    J Immunol; 1992 Jun 01; 148(11):3454-60. PubMed ID: 1316917
    [Abstract] [Full Text] [Related]

  • 42. Particular types of tumor cells have the capacity to convert transforming growth factor beta from a latent to an active form.
    Takiuchi H, Tada T, Li XF, Ogata M, Ikeda T, Fujimoto S, Fujiwara H, Hamaoka T.
    Cancer Res; 1992 Oct 15; 52(20):5641-6. PubMed ID: 1327512
    [Abstract] [Full Text] [Related]

  • 43. Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells.
    Campos SP, Wang Y, Koj A, Baumann H.
    J Immunol; 1993 Dec 15; 151(12):7128-37. PubMed ID: 7505021
    [Abstract] [Full Text] [Related]

  • 44. Retinoic acid causes a decline in TGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line.
    Dmitrovsky E, Moy D, Miller WH, Li A, Masui H.
    Oncogene Res; 1990 Dec 15; 5(3):233-9. PubMed ID: 2320376
    [Abstract] [Full Text] [Related]

  • 45. Molecular cloning of a differentiation-related mRNA in the adipogenic cell line 1246.
    Jiang HP, Harris SE, Serrero G.
    Cell Growth Differ; 1992 Jan 15; 3(1):21-30. PubMed ID: 1376140
    [Abstract] [Full Text] [Related]

  • 46. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
    Cossu G, Kuo AL, Pessano S, Warren L, Cooper RA.
    Cancer Res; 1982 Feb 15; 42(2):484-9. PubMed ID: 6948606
    [Abstract] [Full Text] [Related]

  • 47. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM, Infante D, Winawer S, Friedman E.
    Cell Growth Differ; 1990 Dec 15; 1(12):617-26. PubMed ID: 2288877
    [Abstract] [Full Text] [Related]

  • 48. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, Clark R, McCormick F, Dickson RB, Lippman ME.
    Cancer Res; 1989 Nov 15; 49(22):6269-74. PubMed ID: 2553252
    [Abstract] [Full Text] [Related]

  • 49. All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells.
    Grande A, Manfredini R, Tagliafico E, Balestri R, Pizzanelli M, Papa S, Zucchini P, Bonsi L, Bagnara G, Torelli U.
    Exp Hematol; 1995 Feb 15; 23(2):117-25. PubMed ID: 7530211
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Tumor necrosis factor-alpha, transforming growth factor-beta, and tetradecanoylphorbol acetate: competence factors for ML-1 human myeloblastic leukemia cell differentiation.
    Guan XP, Hromchak RA, Takuma T, Denstman SC, Bloch A.
    Cancer Commun; 1991 Jan 15; 3(1):11-4. PubMed ID: 1989643
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
    Gewirtz AM, Shen YM.
    Exp Hematol; 1990 Sep 15; 18(8):945-52. PubMed ID: 2201557
    [Abstract] [Full Text] [Related]

  • 54. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
    Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I, Fontana A.
    J Immunol; 1989 Nov 15; 143(10):3222-9. PubMed ID: 2809198
    [Abstract] [Full Text] [Related]

  • 55. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line.
    D'Angeac AD, Dornand J, Emonds-Alt X, Jullien P, Garcia-Sanz JA, Erard F.
    J Cell Physiol; 1991 Jun 15; 147(3):460-9. PubMed ID: 2066366
    [Abstract] [Full Text] [Related]

  • 56. Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis.
    Cowley SA, Groopman JE, Avraham H.
    Int J Cell Cloning; 1992 Jul 15; 10(4):223-31. PubMed ID: 1645030
    [Abstract] [Full Text] [Related]

  • 57. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60.
    Stöckbauer P, Gahmberg CG, Andersson LC.
    Cancer Res; 1985 Jun 15; 45(6):2821-6. PubMed ID: 3857122
    [Abstract] [Full Text] [Related]

  • 58. Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation.
    Hafez MM, Hsu S, Yan Z, Winawer S, Friedman E.
    Cell Growth Differ; 1992 Nov 15; 3(11):753-62. PubMed ID: 1334691
    [Abstract] [Full Text] [Related]

  • 59. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate.
    Yu W, Sanders BG, Kline K.
    Nutr Cancer; 1996 Nov 15; 25(2):137-49. PubMed ID: 8710683
    [Abstract] [Full Text] [Related]

  • 60. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL, Benya PD, Padilla SR, Carbonaro-Hall D, Williams R, Buckley S, Warburton D.
    Biochem J; 1996 May 15; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.